In this study, we explored the changes in Asprosin and Nrg-4 levels in patients who have either T2DM alone or CHD secondary to T2DM in order to develop effective diagnostic and predictive strategies. This evidence concerns the gene FBN1 and type 2 diabetes mellitus.